<DOC>
	<DOCNO>NCT00223028</DOCNO>
	<brief_summary>To investigate renal transplant recipient potential drug intreaction Sirolimus , Mycophenolt Mofetil Fluvastatin All patient enrol PKI-Study change therapy study . Only patient without change 4 week startin study include</brief_summary>
	<brief_title>Investigation Steady State Pharmacokinetics Sirolimus , Mycophenolat Mofetil Fluvastatin After Renal Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Fluvastatin</mesh_term>
	<criteria>renal transplant patient ( 18 65 year , inclusive ) cadaver live renal transplant ( 1 . Ntx , 2 . Ntx ) Immunsuppression : sirolimus without Mycophenolat Mofetil und fluvastatin Fluvastatin minimum three month writen informt consent patient contraindication statins pregnancy lactate elevate liver muscle encymes ( &gt; 2x normal value : AST , ALT , bilirubine , CPK )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2004</verification_date>
	<keyword>fluvastain</keyword>
	<keyword>sirolimus</keyword>
	<keyword>mycophenolat mofetil</keyword>
	<keyword>renal transplantation</keyword>
</DOC>